CG Oncology, Inc. (CGON) Reports Q3 Loss of $0.57

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.57). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $20 thousand.

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• PepsiCo (PEP) call put ratio 1.8 calls 1 put with a focus on October calls as share price near low end of range
• Mirum Pharmaceuticals (MIRM) PT Raised to $144 at Citizens